Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martin Lackmann

Showing results (31-40 of 37) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 37 results.
The Journal of Cell Biology|December 7, 2011
Eph receptor function is modulated by heterooligomerization of A and B type Eph receptorsPeter W Janes, Bettina Griesshaber, Lakmali Atapattu, et al.
Nature Neuroscience|April 27, 2004
Repelling class discrimination: ephrin-A5 binds to and activates EphB2 receptor signalingJuha-Pekka Himanen, Michael J Chumley, Martin Lackmann, et al.
The Journal of Cell Biology|September 4, 2003
Proapoptotic BH3-only proteins trigger membrane integration of prosurvival Bcl-w and neutralize its activityJulie Wilson-Annan, Lorraine A O'Reilly, Simon A Crawford, et al.
Cancer Research|August 16, 2014
Targeting EphA3 inhibits cancer growth by disrupting the tumor stromal microenvironmentMary E Vail, Carmel Murone, April Tan, et al.
Cellular Oncology (Dordrecht, Netherlands)|July 20, 2017
EphA3 targeting reduces in vitro adhesion and invasion and in vivo growth and angiogenesis of multiple myeloma cellsFrancesco La Rocca, Irma Airoldi, Emma Di Carlo, et al.
The Journal of Experimental Medicine|August 10, 2016
An activated form of ADAM10 is tumor selective and regulates cancer stem-like cells and tumor growthLakmali Atapattu, Nayanendu Saha, Chanly Chheang, et al.
Cancer Cell|February 16, 2013
EphA3 maintains tumorigenicity and is a therapeutic target in glioblastoma multiformeBryan W Day, Brett W Stringer, Fares Al-Ejeh, et al.
Pageof 4

Showing results (31-40 of 37) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 37 results.
The Journal of Cell Biology|December 7, 2011
Eph receptor function is modulated by heterooligomerization of A and B type Eph receptorsPeter W Janes, Bettina Griesshaber, Lakmali Atapattu, et al.
Nature Neuroscience|April 27, 2004
Repelling class discrimination: ephrin-A5 binds to and activates EphB2 receptor signalingJuha-Pekka Himanen, Michael J Chumley, Martin Lackmann, et al.
The Journal of Cell Biology|September 4, 2003
Proapoptotic BH3-only proteins trigger membrane integration of prosurvival Bcl-w and neutralize its activityJulie Wilson-Annan, Lorraine A O'Reilly, Simon A Crawford, et al.
Cancer Research|August 16, 2014
Targeting EphA3 inhibits cancer growth by disrupting the tumor stromal microenvironmentMary E Vail, Carmel Murone, April Tan, et al.
Cellular Oncology (Dordrecht, Netherlands)|July 20, 2017
EphA3 targeting reduces in vitro adhesion and invasion and in vivo growth and angiogenesis of multiple myeloma cellsFrancesco La Rocca, Irma Airoldi, Emma Di Carlo, et al.
The Journal of Experimental Medicine|August 10, 2016
An activated form of ADAM10 is tumor selective and regulates cancer stem-like cells and tumor growthLakmali Atapattu, Nayanendu Saha, Chanly Chheang, et al.
Cancer Cell|February 16, 2013
EphA3 maintains tumorigenicity and is a therapeutic target in glioblastoma multiformeBryan W Day, Brett W Stringer, Fares Al-Ejeh, et al.
Pageof 4